SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 35 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,701 | -43.8% | 10,876 | -19.9% | 0.00% | – |
| Q2 2023 | $15,477 | -32.5% | 13,576 | -11.1% | 0.00% | – |
| Q1 2023 | $22,914 | -50.5% | 15,276 | -50.8% | 0.00% | – |
| Q4 2022 | $46,303 | -15.8% | 31,076 | -13.1% | 0.00% | – |
| Q3 2022 | $55,000 | -37.5% | 35,776 | -7.7% | 0.00% | – |
| Q2 2022 | $88,000 | -38.9% | 38,776 | -37.6% | 0.00% | – |
| Q1 2022 | $144,000 | -13.8% | 62,184 | +116.1% | 0.00% | – |
| Q4 2021 | $167,000 | -7.7% | 28,771 | +55.1% | 0.00% | – |
| Q2 2021 | $181,000 | -73.0% | 18,551 | -59.8% | 0.00% | -100.0% |
| Q1 2021 | $670,000 | – | 46,112 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Newtyn Management, LLC | 1,540,920 | $2,311,380 | 0.45% |
| Deuterium Capital Management, LLC | 11,000 | $16,500 | 0.03% |
| Duquesne Family Office | 100,000 | $150 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 112,900 | $169,350 | 0.00% |
| LEO BROKERAGE, LLC | 14,845 | $22,268 | 0.00% |
| Ergoteles LLC | 15,521 | $23,282 | 0.00% |
| UBS Group AG | 3,440 | $5,160 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 15,276 | $22,914 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 11,570 | $17,355 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 89,986 | $134,979 | 0.00% |